Board of Directors

Home/About Us/Board of Directors
Board of Directors 2022-05-25T15:36:00+10:00

<b>Zita Peach</b> <i>BSc, GAICD, FAMI</i>
Zita Peach BSc, GAICD, FAMINon Executive Chairman, appointed February 2020. Member of the Nomination and Remuneration Committee.
Zita has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices and health services industries. She has extensive sales and marketing experience across a broad range of sectors in healthcare, locally and internationally, as well as leading international expansions and conducting major business transactions. At leading global healthcare company Fresenius Kabi, Zita was Executive Vice President for South Asia Pacific, Managing Director for Australia and New Zealand and Chair of the Boards for Malaysia, Australia and New Zealand. Zita was Vice President of Business Development at CSL Limited and has an extensive track record in mergers and acquisitions deals, licencing and commercialising products and technologies on a global scale. Zita is a Non-executive Director of Monash IVF Group Limited, Starpharma Holdings Limited and Visioneering Technologies, Inc. Zita is also a member of the Hudson Institute of Medical Research Board. Zita is a Fellow of the Australian Institute of Company Directors and a Fellow of the Australian Marketing Institute.

<b>Phil McKenzie </b><i>B.Bus (Auckland Uni)</i>
Phil McKenzie B.Bus (Auckland Uni)Chief Executive Officer/ Managing Director, appointed October 2018.
Prior to joining Pacific Smiles, Phil was Chief Executive Officer for Audiology Management Group (AMG), a leading audiology services business with a network of more than 200 clinic locations across the USA. During his time at AMG, Phil balanced and transitioned the model from acquisition-driven to greenfield expansion and delivered strong financial performance for the group. Prior to his role as CEO of AMG, Phil was CEO of Widex Australia, New Zealand, Singapore, Hong Kong and India retail where he successfully turned around and grew those operations. Phil has also held leadership positions at Apple Retail as Australian Market Director and was a driver of Apple’s retail entry into the Australian market from 2008 to 2011, and Luxottica as National Operations Manager from 2005 to 2007.
<b>Mark Bloom </b><i>B Com. B Acc. C.A. ANZ</i>
Mark Bloom B Com. B Acc. C.A. ANZNon Executive Director - Appointed October 2019. Member of the Audit and Risk Management Committee
Up until April 2019, Mark held the position of Chief Financial Officer at ASX 20 listed Scentre Group Limited (Owner and operator of Westfield in Australia and NZ). Mark’s executive career as a Finance Executive has spanned 36 years as Chief Financial Officer and an Executive Director at 3 top 20 listed entities in Real Estate (Westfield and Scentre Group – 16 years) and Insurance and diversified Financial Services (Liberty Life, South Africa and Manulife Financial, Toronto – 20 years). He has had extensive experience in running global and local Finance and IT teams encompassing Treasury, Tax, Operations Finance, Compliance, Risk Management, Financial Reporting, Legal and Information Technology. Mark has extensive experience in corporate transactions and restructuring. Mark is a Non-executive Director at AGL Energy Limited and Abacus Property Group.

<b>Hilton Brett</b> <i>BCom PGDA</i>
Hilton Brett BCom PGDANon-executive Director, appointed August 2018. Chairman of the Nomination and Remuneration Committee. Member of the Audit and Risk Management Committee from August 2018 until April 2019
Hilton is an Operating Advisor at TDM Growth Partners (TDM), a private global investment firm founded in 2004, with offices in Sydney and New York which invests in fast growing companies run by passionate management teams. Hilton is a Non-Executive Director of Guzman Y Gomez Mexican Taqueria (GYG), and  Somnomed Ltd (SOM:ASX). Prior to joining TDM, Hilton was the Co-CEO of Accent Group Limited (AX1), formerly RCG Corporation Ltd, which is the regional leader in the retail and distribution of performance and lifestyle footwear Australia and New Zealand. Hilton joined RCG in 2006 when the  business had a market capitalisation of $8m. Over the 12 years from 2006 to 2018, the team grew the business to a $800m market capitalisation and delivered total shareholder returns in excess of 25% CAGR. Hilton has over 25 years experience as CEO of multiple consumer businesses with proven skills in growing  the businesses and delivering outstanding returns for shareholders.

<b>Simon Rutherford </b> <i>BComm, CA, FAICD</i>
Simon Rutherford BComm, CA, FAICDNon-executive Director, appointed in 2003. Chairman of the Audit and Risk Management Committee
Simon is a chartered accountant and partner with PKF in business advisory services. He has been with the firm for 36 years. He works with corporate and family owned groups as an advisory board member and lead adviser on strategy, governance, structuring, business sales, mergers and acquisitions. He is also a Director of PKF Wealth. In his role Simon has assisted various companies with capital raising and listing requirements. Simon was a director of the Trustee of Canyon Property Trust and is involved with other syndicated investments. He has also served on a number of boards including National Brokers Group and Vow Financial Group.

<strong>Dr Scott Kalniz</strong> <em>Doctor of Dental Surgery, Bachelor of Science in Business Administration</em>
Dr Scott Kalniz Doctor of Dental Surgery, Bachelor of Science in Business AdministrationNon-executive Director, appointed in January 2021. Member of the Audit and Risk Management Committee.
Dr. Kalniz has over 20 years of dental industry experience in the United States. He started his career as a practicing dentist with a single location practice and purchased a number of other dental practices, eventually selling his group to North American Dental. At North American Dental, he helped grow the business to over 50 locations. Dr. Kalniz then partnered with a private equity firm, as CEO and Chief Dental Officer, to create a new Chicago headquartered Dental Services Organisation (DSO), Elite Dental Partners. In under 5 years, the business grew to over 110 locations in 12 states. Dr. Kalniz retired from the Board of Elite Dental Partners in September 2020. Dr. Kalniz currently serves as a Non-Executive Director of Signature Dental Partners, a DSO based in Phoenix, Arizona. Dr. Kalniz also previously served on the Board of Heartland Veterinary Partners.


<b>Andrew Knott</b> <i>B Bus, Marketing and Finance.</i>
Andrew Knott B Bus, Marketing and Finance.Non-Executive Director - Appointed February 2022.Member of the Nomination and Remuneration Committee.
Up until January 2022, Andrew held the role of President – Verizon within the Advertising Agency, the Publicis Groupe. Leading over 850 staff delivering across media, customer experience, data and analytics, marketing optimisation and creative for Verizon Consumer, Business, and Media Groups, Andrew was accountable for accelerating change for marketing, channel development, sales effectiveness, customer analytics and operations, overseeing $1.5bn in client spend and delivering over $200m in group revenue. On the operating business side, Andrew has held Chief Marketing roles at JPMorgan Chase & Co, National Australia Bank (NAB) and as Vice President Digital Transformation and Marketing at McDonald’s. Andrew has extensive experience as a senior executive in Australia, Asia Pacific and the United States.